Computational Biology Dynamics of Mps1 Kinase Molecular Interactions with Isoflavones Reveals a Chemical Scaffold with Potential to Develop New Therapeutics for the Treatment of Cancer

被引:2
作者
Pugh, Lauren [1 ]
Pancholi, Alisha [1 ]
Purat, Priscila Celeste [1 ]
Agudo-Alvarez, Sandra [2 ]
Benito-Arenas, Raul [2 ]
Bastida, Agatha [2 ]
Bolanos-Garcia, Victor M. [1 ]
机构
[1] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Gipsy Lane, Oxford OX3 0BP, England
[2] IQOG, Dept Quim Bioorgan, C Juan de la Cierva 3, E-28006 Madrid, Spain
关键词
Mps1; cancer; poor prognosis tumours; flavonoid-like compounds; bioinformatics; molecular docking; CRYSTAL-STRUCTURE; TPR DOMAIN; INHIBITORS; PROTEIN; GENISTEIN; ASSAY; CHEMOPREVENTION; PHOSPHORYLATES; CFI-402257; PREVENTION;
D O I
10.3390/ijms232214228
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein kinase Mps1 (monopolar spindle 1) is an important regulator of the Spindle Assembly Checkpoint (SAC), the evolutionary conserved checkpoint system of higher organisms that monitors the proper bipolar attachment of all chromosomes to the mitotic spindle during cell division. Defects in the catalytic activity and the transcription regulation of Mps1 are associated with genome instability, aneuploidy, and cancer. Moreover, multiple Mps1 missense and frameshift mutations have been reported in a wide range of types of cancer of different tissue origin. Due to these features, Mps1 arises as one promising drug target for cancer therapy. In this contribution, we developed a computational biology approach to study the dynamics of human Mps1 kinase interaction with isoflavones, a class of natural flavonoids, and compared their predicted mode of binding with that observed in the crystal structure of Mps1 in complex with reversine, a small-sized inhibitor of Mps1 and Aurora B kinases. We concluded that isoflavones define a chemical scaffold that can be used to develop new Mps1 inhibitors for the treatment of cancer associated with Mps1 amplification and aberrant chromosome segregation. In a broader context, the present report illustrates how modern chemoinformatics approaches can accelerate drug development in oncology.
引用
收藏
页数:17
相关论文
共 73 条
  • [1] High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers
    Anderhub, Simon J.
    Mak, Grace Wing-Yan
    Gurden, Mark D.
    Faisal, Amir
    Drosopoulos, Konstantinos
    Walsh, Katie
    Woodward, Hannah L.
    Innocenti, Paolo
    Westwood, Isaac M.
    Naud, Sebastien
    Hayes, Angela
    Theofani, Efthymia
    Filosto, Simone
    Saville, Harry
    Burke, Rosemary
    van Montfort, Rob L. M.
    Raynaud, Florence, I
    Blagg, Julian
    Hoeder, Swen
    Eccles, Suzanne A.
    Linardopoulos, Spiros
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1696 - 1707
  • [2] New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
    Baell, Jonathan B.
    Holloway, Georgina A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) : 2719 - 2740
  • [3] Emerging drug profile: cyclin-dependent kinase inhibitors
    Blachly, James S.
    Byrd, John C.
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2133 - 2143
  • [4] The right place at the right time: Aurora B kinase localization to centromeres and kinetochores
    Broad, Amanda J.
    DeLuca, Jennifer G.
    [J]. KINETOCHORES AND CHROMOSOME SEGREGATION, 2020, 64 (02): : 299 - 311
  • [5] Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS
    Capuzzi, Stephen J.
    Muratov, Eugene N.
    Tropsha, Alexander
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (03) : 417 - 427
  • [6] CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma
    Chan, Cerise Yuen-Ki
    Chiu, David Kung-Chun
    Yuen, Vincent Wai-Hin
    Law, Cheuk-Ting
    Wong, Bowie Po-Yee
    Thu, Kelsie Lynn
    Cescon, David Ward
    Soria-Bretones, Isabel
    Cheu, Jacinth Wing-Sum
    Lee, Derek
    Tse, Aki Pui-Wah
    Zhang, Misty Shuo
    Tan, Kel Vin
    Ng, Irene Oi-Lin
    Khong, Pek-Lan
    Yau, Thomas Chung-Cheung
    Bray, Mark Robert
    Mak, Tak Wah
    Wong, Carmen Chak-Lui
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (32)
  • [7] Identification of the hot spot residues for pyridine derivative inhibitor CCT251455 and ATP substrate binding on monopolar spindle 1 (MPS1) kinase by molecular dynamic simulation
    Chen, Kai
    Duan, Wenxiu
    Han, Qianqian
    Sun, Xuan
    Li, Wenqian
    Hu, Shuangyun
    Wan, Jiajia
    Wu, Jiang
    Ge, Yushu
    Liu, Dan
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (03) : 611 - 622
  • [8] Comparison of Phenolic and Flavonoid Compound Profiles and Antioxidant and α-Glucosidase Inhibition Properties of Cultivated Soybean (Glycine max) and Wild Soybean (Glycine soja)
    Chen, Qianru
    Wang, Xianxian
    Yuan, Xiaolong
    Shi, John
    Zhang, Chengsheng
    Yan, Ning
    Jing, Changliang
    [J]. PLANTS-BASEL, 2021, 10 (04):
  • [9] TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability
    Choi, Minji
    Min, Yoo Hong
    Pyo, Jaehyuk
    Lee, Chang-Woo
    Jang, Chang-Young
    Kim, Ja-Eun
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (12) : 1810 - 1825
  • [10] Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125
    Chu, Matthew L. H.
    Chavas, Leonard M. G.
    Douglas, Kenneth T.
    Eyers, Patrick A.
    Tabernero, Lydia
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (31) : 21495 - 21500